Chicago Equity Partners’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-4,380
Closed -$349K 837
2016
Q3
$349K Sell
4,380
-2,530
-37% -$204K 0.01% 616
2016
Q2
$539K Sell
6,910
-1,855
-21% -$132K 0.02% 495
2016
Q1
$482K Sell
8,765
-113,485
-93% -$6.18M 0.01% 477
2015
Q4
$7.55M Buy
122,250
+14,785
+14% +$932K 0.2% 130
2015
Q3
$6.78M Buy
107,465
+100,780
+1,508% +$7.19M 0.19% 128
2015
Q2
$488K Buy
6,685
+330
+5% +$23.8K 0.01% 341
2015
Q1
$416K Buy
6,355
+600
+10% +$39.9K 0.01% 358
2014
Q4
$374K Sell
5,755
-21,305
-79% -$1.37M 0.01% 327
2014
Q3
$1.63M Sell
27,060
-500
-2% -$32.7K 0.04% 239
2014
Q2
$1.91M Sell
27,560
-5,660
-17% -$367K 0.05% 224
2014
Q1
$2.17M Sell
33,220
-444,645
-93% -$28.9M 0.06% 215
2013
Q4
$29.6M Sell
477,865
-294,310
-38% -$17M 0.89% 33
2013
Q3
$41.4M Sell
772,175
-104,305
-12% -$5.37M 1.28% 14
2013
Q2
$40M Buy
+876,480
New +$38M 1.24% 16

Other funds holding STJ

Chicago Equity Partners's STJ Position: Q4 2016 in Review

Chicago Equity Partners sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 4,380 shares — an estimated $349K sold.

Chicago Equity Partners first reported a position in STJ in Q2 2013 and held it in 14 quarters. The position peaked at $41.4M in Q3 2013. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • Chicago Equity Partners reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • Chicago Equity Partners sold 4,380 St Jude Medical shares in Q4 2016, an estimated $349K.
  • Chicago Equity Partners first reported a position in St Jude Medical in Q2 2013 and held it in 14 quarters.
  • Chicago Equity Partners's St Jude Medical position peaked at $41.4M in Q3 2013.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Chicago Equity Partners's 13F filing for Q4 2016, filed 2 Feb 2017.